Healthcare

Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2

BEIJING and BRIDGEWATER, N.J., March 31, 2026, 09:47 GMT-04

GanLee-Pharma

Read full article →

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

TAMPA, Fla., March 31, 2026, 03:56 GMT-04

Concept-Medical

Read full article →

Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program

GOTHENBURG, Sweden, March 31, 2026, 03:16 GMT-04

CERENO-CS1-PAH-safety

Read full article →

Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M

HERZLIYA, Israel and CALGARY, AB, March 31, 2026, 03:04 GMT-04

Innocan-2025-Results

Read full article →

DNV SELECTED TO CERTIFY CLASS D DEVICES FOR LEADING U.S. MANUFACTURER UNDER EU IVDR

OSLO, Norway, March 31, 2026, 03:00 GMT-04

DNV-EU-IVDR

Read full article →

Tigermed Announces 2025 Annual Results

HANGZHOU, China, March 30, 2026, 09:05 GMT-04

Tigermed-25-Reults

Read full article →

CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"

SEOUL, South Korea and BANGKOK, March 30, 2026, 08:00 GMT-04

CGBIO-Thailand

Read full article →

Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026

SANTA CRUZ, Calif., March 30, 2026, 08:00 GMT-04

Emboline-PROTECT-H2H

Read full article →

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants

CORAL SPRINGS, Fla., March 30, 2026, 07:30 GMT-04

Neurolief

Read full article →

EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

STOCKHOLM, March 30, 2026, 02:23 GMT-04

SOBI-EMA

Read full article →

Singclean Global Aesthetic Master Symposium Makes Landmark Debut in Monaco

MONACO, March 30, 2026, 23:30 GMT-04

HangzhouSingclean

Read full article →

Smartee Advances "Mandibular Repositioning" Solutions in the UK with Specialized Clinical Conference in London

LONDON, March 29, 2026, 14:03 GMT-04

Smartee-Denti-Techn

Read full article →

Landmark ALL-RISE® Trial Results Presented at ACC.26: CathWorks FFRangio Demonstrates Similar Clinical Outcomes to Invasive Wire-based Physiology Assessment

NEW ORLEANS, March 29, 2026, 10:00 GMT-04

CathWorks-ACC

Read full article →

Foshan Launches First Provincial-Level International Medical Pilot

FOSHAN, China, March 29, 2026, 03:11 GMT-04

Fosun-Health

Read full article →

UK Soft Gelatin Capsules Market to Reach USD 408.07 Million by 2032, Growing at a CAGR of 5.8% During 2026-2032 | MarkNtel Advisors

NEW DELHI, March 28, 2026, 14:31 GMT-04

MarkNtel-Advisors

Read full article →

Rehab clinic launches trauma-informed programme to tackle root causes of addiction

CHESTER, England, March 28, 2026, 03:30 GMT-04

DELAMERE-HEALTH-rehab

Read full article →

Brazil Digestive Remedies Market to Reach USD 1.11 Billion by 2032, Says Vyansa Intelligence

NEW DELHI, March 28, 2026, 00:09 GMT-04

VYANSA-INTELLIGENCE

Read full article →

Better by MTA Expands Its Global Elite Network with Distinguished New Platinum Members

PALM BEACH GARDENS, Fla., March 27, 2026, 10:34 GMT-04

MTA-Platinum-Members

Read full article →

Global Paediatric Consumer Health Market to Reach USD 254 Billion by 2032 Amid Growing Focus on Child Wellness and Nutrition, Reports Vyansa Intelligence

NEW DELHI, March 27, 2026, 10:01 GMT-04

VYANSA-INTELLIGENCE

Read full article →

Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale

TUCSON, Ariz. and AMSTERDAM, March 26, 2026, 14:17 GMT-04

One-to-Millions

Read full article →